ARIMIDEX 1 - BioTeq Labs

Anastrozole, introduced as Arimidex by AstraZeneca, functions as a selective aromatase inhibitor, originally developed to treat breast cancer in postmenopausal women. By blocking the aromatase enzyme, it prevents the conversion of testosterone to estrogen, significantly lowering estrogen levels in the body. This action gained it widespread use in the bodybuilding community, where it helps prevent gynecomastia, water retention, and estrogenic fat gain during anabolic steroid cycles. Athletes favor it for maintaining lean muscle definition while minimizing unwanted estrogenic effects.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about ARIMIDEX 1 by BioTeq Labs, consult with your doctor or healthcare professional.